Cencora, Inc.
CORA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Cencora fiscal 2026 fourth-quarter results
Cencora will release fiscal 2026 fourth-quarter results before the New York Stock Exchange opens on November 4. Pharmaceutical distribution volumes, service revenue and the fiscal 2027 outlook will be closely watched.
Cencora ↗Cencora fiscal-year earnings call
Cencora management will discuss fiscal fourth-quarter results at 8:30 AM ET on November 4, equivalent to 16:30 in Istanbul. Distribution margins, specialty pharmaceuticals and the new fiscal-year outlook will be in focus.
Cencora ↗More NYSE records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Issuer source connected
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.